Jean Strelitz1, Lawrence S Engel1, Matthew C Keifer2. 1. Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA. 2. National Farm Medicine Center, Marshfield Clinic Research Foundation, Marshfield, Wisconsin, USA.
Abstract
OBJECTIVE: Agricultural pesticide handlers are at an elevated risk for overexposure to organophosphate (OP) pesticides, but symptoms can be difficult to recognise, making biomarkers invaluable for diagnosis. Occupational monitoring programmes for cholinesterase depression generally rely on measuring activity of either of the two common blood cholinesterases which serve as proxy measurements for nervous-system acetylcholinesterase activity: red blood cell acetylcholinesterase (AChE) and plasma butyrylcholinesterase (BChE). These biomarkers, however, may be affected differentially by some OPs and the relationship between them has not been well characterised. We aim to determine the association between blood AChE and BChE activity levels and assess whether they produce comparable classifications of clinical cholinesterase depression among OP pesticide handlers. METHODS: Using blood samples from 215 participants of the Washington State Cholinesterase Monitoring Program, we quantified changes in AChE and BChE activity from before and after exposure to OP pesticides and calculated Pearson correlation statistics for correlation of AChE and BChE changes in activity, as well as weighted κ statistics for agreement of classification of clinical cholinesterase depression based on AChE versus BChE measurements. RESULTS: AChE and BChE activity measurements are weakly negatively correlated in our study population. Reaching a clinical threshold for diagnosis of cholinesterase depression based on the AChE marker did not correlate with reaching clinical depression based on the BChE marker. CONCLUSIONS: Both AChE and BChE should be measured in monitoring programmes because they may both give potentially important but disparate classifications of clinical cholinesterase depression. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
OBJECTIVE: Agricultural pesticide handlers are at an elevated risk for overexposure to organophosphate (OP) pesticides, but symptoms can be difficult to recognise, making biomarkers invaluable for diagnosis. Occupational monitoring programmes for cholinesterase depression generally rely on measuring activity of either of the two common blood cholinesterases which serve as proxy measurements for nervous-system acetylcholinesterase activity: red blood cell acetylcholinesterase (AChE) and plasma butyrylcholinesterase (BChE). These biomarkers, however, may be affected differentially by some OPs and the relationship between them has not been well characterised. We aim to determine the association between blood AChE and BChE activity levels and assess whether they produce comparable classifications of clinical cholinesterase depression among OP pesticide handlers. METHODS: Using blood samples from 215 participants of the Washington State Cholinesterase Monitoring Program, we quantified changes in AChE and BChE activity from before and after exposure to OP pesticides and calculated Pearson correlation statistics for correlation of AChE and BChE changes in activity, as well as weighted κ statistics for agreement of classification of clinical cholinesterase depression based on AChE versus BChE measurements. RESULTS:AChE and BChE activity measurements are weakly negatively correlated in our study population. Reaching a clinical threshold for diagnosis of cholinesterase depression based on the AChE marker did not correlate with reaching clinical depression based on the BChE marker. CONCLUSIONS: Both AChE and BChE should be measured in monitoring programmes because they may both give potentially important but disparate classifications of clinical cholinesterase depression. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
Authors: Mustafa Dosemeci; Michael C R Alavanja; Andrew S Rowland; David Mage; Shelia Hoar Zahm; Nathaniel Rothman; Jay H Lubin; Jane A Hoppin; Dale P Sandler; Aaron Blair Journal: Ann Occup Hyg Date: 2002-03
Authors: W R Christenson; D L Van Goethem; R S Schroeder; B S Wahle; P D Dass; G K Sangha; J H Thyssen Journal: Toxicol Lett Date: 1994-04 Impact factor: 4.372
Authors: C Espinosa da Silva; S Gahagan; J Suarez-Torres; D Lopez-Paredes; H Checkoway; J R Suarez-Lopez Journal: Environ Res Date: 2021-11-03 Impact factor: 8.431
Authors: Susan Woskie; Pornpimol Kongtip; Wiroj Thanasanpaiboon; Napaporn Kiatdamrong; Nantha Charoonrungsirikul; Noppanun Nankongnab; Anu Surach; Akkarat Phamonphon Journal: Int J Occup Environ Health Date: 2018-03-15
Authors: Jacek Mamczarz; Joseph D Pescrille; Lisa Gavrushenko; Richard D Burke; William P Fawcett; Louis J DeTolla; Hegang Chen; Edna F R Pereira; Edson X Albuquerque Journal: Neurotoxicology Date: 2016-06-11 Impact factor: 4.294
Authors: Jose Ricardo Suarez-Lopez; Cheyenne R Butcher; Sheila Gahagan; Harvey Checkoway; Bruce H Alexander; Wael K Al-Delaimy Journal: Int Arch Occup Environ Health Date: 2017-10-13 Impact factor: 3.015
Authors: Rafael Valencia-Quintana; Rosa María López-Durán; Mirta Milić; Stefano Bonassi; Ma Antonieta Ochoa-Ocaña; Mayrut Osdely Uriostegui-Acosta; Guillermo Alejandro Pérez-Flores; José Luis Gómez-Olivares; Juana Sánchez-Alarcón Journal: Int J Environ Res Public Health Date: 2021-06-10 Impact factor: 3.390
Authors: Joanna Jońca; Monika Żuk; Bartosz Wasąg; Anna Janaszak-Jasiecka; Krzysztof Lewandowski; Bartosz Wielgomas; Krzysztof Waleron; Jacek Jasiecki Journal: PLoS One Date: 2015-10-07 Impact factor: 3.240